Inhibitory Activities of Quinolones against DNA Gyrase of Chlamydia pneumoniae
AUTOR(ES)
Ameyama, Satoshi
FONTE
American Society for Microbiology
RESUMO
The gyrA and gyrB genes of Chlamydia pneumoniae TW-183 were cloned, and their proteins were purified by use of a fusion system with a maltose-binding protein. The 50% inhibitory concentrations of garenoxacin, sparfloxacin, moxifloxacin, gatifloxacin, and levofloxacin were 10.1, 47.5, 39.6, 64.2, and 156.9 μg/ml, respectively, and the MICs against C. pneumoniae TW-183 were 0.008, 0.016, 0.063, 0.125, and 0.25 μg/ml, respectively.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=161870Documentos Relacionados
- Inhibitory Activities of Quinolones against DNA Gyrase and Topoisomerase IV of Enterococcus faecalis
- Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.
- In vitro activities of five quinolones against Chlamydia pneumoniae.
- Mechanism of action of quinolones against Escherichia coli DNA gyrase.
- DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.
